Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
J Exp Clin Cancer Res. 2022 Jun 3;41(1):192. doi: 10.1186/s13046-022-02394-2.
J Exp Clin Cancer Res. 2022.
PMID: 35655220
Free PMC article.
The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans.
Zhang S, Zhang J, Evert K, Li X, Liu P, Kiss A, Schaff Z, Ament C, Zhang Y, Serra M, Evert M, Chen N, Xu F, Chen X, Tao J, Calvisi DF, Cigliano A.
Zhang S, et al.
Am J Pathol. 2020 Jul;190(7):1397-1413. doi: 10.1016/j.ajpath.2020.03.011. Epub 2020 Apr 10.
Am J Pathol. 2020.
PMID: 32283103
Free PMC article.
Item in Clipboard
Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans.
Wang H, Song X, Liao H, Wang P, Zhang Y, Che L, Zhang J, Zhou Y, Cigliano A, Ament C, Superville D, Ribback S, Reeves M, Pes GM, Liang B, Wu H, Evert M, Calvisi DF, Zeng Y, Chen X.
Wang H, et al.
Hepatology. 2021 Jul;74(1):248-263. doi: 10.1002/hep.31692. Epub 2021 Jun 15.
Hepatology. 2021.
PMID: 33368437
Free PMC article.
Item in Clipboard
YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice.
Lu X, Peng B, Chen G, Pes MG, Ribback S, Ament C, Xu H, Pal R, Rodrigues PM, Banales JM, Evert M, Calvisi DF, Chen X, Fan B, Wang J.
Lu X, et al.
Am J Pathol. 2021 Sep;191(9):1651-1667. doi: 10.1016/j.ajpath.2021.05.017. Epub 2021 Jun 12.
Am J Pathol. 2021.
PMID: 34129844
Free PMC article.
Item in Clipboard
Fascin1 empowers YAP mechanotransduction and promotes cholangiocarcinoma development.
Pocaterra A, Scattolin G, Romani P, Ament C, Ribback S, Chen X, Evert M, Calvisi DF, Dupont S.
Pocaterra A, et al.
Commun Biol. 2021 Jun 21;4(1):763. doi: 10.1038/s42003-021-02286-9.
Commun Biol. 2021.
PMID: 34155338
Free PMC article.
Item in Clipboard
Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma.
Ament CE, Steinmann S, Evert K, Pes GM, Ribback S, Gigante I, Pizzuto E, Banales JM, Rodrigues PM, Olaizola P, Wang H, Giannelli G, Chen X, Evert M, Calvisi DF.
Ament CE, et al.
Hepatology. 2023 Dec 1;78(6):1742-1754. doi: 10.1097/HEP.0000000000000322. Epub 2023 Feb 16.
Hepatology. 2023.
PMID: 36789652
Item in Clipboard
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
Cigliano A, Zhang S, Ribback S, Steinmann S, Sini M, Ament CE, Utpatel K, Song X, Wang J, Pilo MG, Berger F, Wang H, Tao J, Li X, Pes GM, Mancarella S, Giannelli G, Dombrowski F, Evert M, Calvisi DF, Chen X, Evert K.
Cigliano A, et al. Among authors: ament ce.
J Exp Clin Cancer Res. 2023 May 17;42(1):124. doi: 10.1186/s13046-023-02709-x.
J Exp Clin Cancer Res. 2023.
PMID: 37194029
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite